The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -26.44 — distress zone — historically elevated failure riskWatch
Leadership changes
From Shuttle Pharmaceuticals Holdings, Inc.'s own filings, the day they're filed.
- Christopher Cooper · Chief Executive Officer · appointmenteff. 2025-11-21
- Timothy Lorber · Chief Financial Officer · departureeff. 2025-11-21
- Angel Liriano · directors · appointmenteff. 2025-09-12
Latest filings
- 8-K · Company announcement2026-06-11
- 8-K · Company announcement2026-05-27
- 10-Q · Quarterly report2026-05-15
- 8-K · Company announcement2026-05-07
- 8-K · Company announcement2026-05-01
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Shuttle Pharmaceuticals Holdings, Inc., every answer cited🔒
- The Intelligence Brief — added when Shuttle Pharmaceuticals Holdings, Inc.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.